In better news: They're totally treatable and actually pretty common (especially for makeup wearers).

Welcome to the Barclays Miami Healthcare Conference. I'm Jenna Davidner. I'm one of the analysts here on the specialty pharmaceuticals team and very pleased to have Tarsus Pharmaceuticals on the stage ...

Irvine-based Tarsus Pharmaceuticals posted blockbuster Q4 and full year revenues driven by surging demand for its eyedrop ...

Eyelash extensions may contribute to blepharitis, dry eye disease, and corneal injury through meibomian gland dysfunction.

Discover how menopause affects eye health, from dry eyes to vision changes, and the importance of regular eye evaluations.

Generated full-year 2025 net product sales of XDEMVY® of $451.4 million, an increase of more than 150% year-over-year ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is among the 10 Fastest Growing NASDAQ Stocks to Buy. On February 25, 2026, ...

Citi analyst Joanne Wuensch reiterated a Buy rating on Glaukos today and set a price target of $125.00. According to TipRanks, Wuensch is a 4-star analyst with an average return of 3.8% and a 55.83% ...

OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...

If you also fancy a bold eye makeup look, make sure you take care of your vision as well. Here are some doctor-approved tips to keep your eyes safe.

IRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: TD ...

There are several reasons why vision may decline in early childhood. This was announced on March 8 by Amina Ausheva, a pediatric ophthalmologist of the first category at the Center for Vision ...